SCHEMBL4740952

SCHEMBL4740952

CC(O)(c1cccs1)c1cncs1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.35
CYP2C19 P33261 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP17A1 P05093 1/20 0.35
CNR1 P21554 3/20 0.34
CNR2 P34972 3/20 0.34
CHRM3 P20309 3/20 0.33
CYP2D6 P10635 1/20 0.32
TSHR P16473 1/20 0.32
ESR1 P03372 1/20 0.32
RGS12 O14924 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
CYP2E1 P05181 1/20 0.31
CYP2A6 P11509 1/20 0.31
CYP2B6 P20813 1/20 0.31
ALDH1A1 P00352 1/20 0.30
GAA P10253 1/20 0.30
HSD17B10 Q99714 1/20 0.30
MAP3K14 Q99558 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5731973 0.84 CNR1 (0.41) CYP2C9CYP2C19CNR1CNR2CHRM3
SCHEMBL8690413 0.79 CYP3A4 (0.38) CYP2C9CYP2C19CYP3A4CYP17A1TSHR
SCHEMBL8615318 0.75 CYP3A4 (0.36) CYP2C9CYP2C19CYP3A4CYP17A1CHRM3
SCHEMBL19475219 0.74
SCHEMBL14777822 0.72
SCHEMBL5164470 0.72
SCHEMBL12006685 0.72 CNR1 (0.41) CYP2C9CYP2C19CNR1CNR2CHRM3
SCHEMBL3906605 0.72 RGS12 (0.44) CYP2C19CYP3A4CNR1CNR2CHRM3
SCHEMBL8616899 0.71 CNR1 (0.33) CNR1CNR2CHRM3ESR1
SCHEMBL27817636 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1999119-A2 NOVEL ACETYL-COA CARBOXYLASE (ACC) INHIBITORS AND THEIR USE IN DIABETES, OBESITY AND METABOLIC SYNDROME Abbott Laboratories (US) 2008-12-10 EP disclosed
WO-2007095602-A2 NOVEL ACETYL-COA CARBOXYLASE (ACC) INHIBITORS AND THEIR USE IN DIABETES, OBESITY AND METABOLIC SYNDROME ABBOTT LABORATORIES (US) 2007-08-23 WO disclosed